PEFG REGIMEN (CISPLATIN, EPIRUBICIN, 5-FLUOROURACIL, GEMCITABINE) VERSUS GEMCITABINE (G): A PHASE III TRIAL IN ADVANCED PANCREATIC ADENOCARCINOMA (PA). TIME TO ABANDON SINGLE-AGENT THERAPY?

被引：0
|
作者：
Reni, Michele [1 ]
Cordio, Stefano [2 ]
Passardi, Alessandro [3 ]
Bonetto, Elisa [1 ]
Passoni, Paolo [1 ]
Oliani, Cristina [4 ]
Luppi, Gabriele [5 ]
Nicoletti, Roberto
Galli, Laura
Bordonaro, Roberto [2 ]
Milandri, Carlo [3 ]
Aldrighetti, Luca
Staudacher, Carlo
Di Carlo, Valerio
Villa, Eugenio [1 ]
机构：
[1] S Raffaele H Sci Inst, Dept Radiochemotherapy, Milan, Italy
[2] S Luigi Curro H, Dept Oncol, Catania, Italy
[3] Pierantoni H, Forli, Italy
[4] Borgo Trento H, Verona, Italy
[5] Univ Modena Policlin, Modena, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [1] The Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine (PEFG) Regimen in Advanced Biliary Tract Adenocarcinoma
    Cereda, Stefano
    Passoni, Paolo
    Reni, Michele
    Vigano, Maria G.
    Aldrighetti, Luca
    Nicoletti, Roberto
    Villa, Eugenio
    CANCER, 2010, 116 (09) : 2208 - 2214
  • [2] PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen in advanced biliary tract adenocarcinoma (BTA)
    Cereda, Stefano
    Reni, Michele
    Ronzoni, Monica
    Vigano, Maria Grazia
    Vitali, Giordano
    Mereu, Antonio
    Aldrighetti, Luca
    Zanello, Alessandro
    Villa, Eugenio
    Passoni, Paolo
    ANNALS OF ONCOLOGY, 2006, 17 : 319 - 320
  • [3] PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: The ghost regimen
    Reni, M.
    Cereda, S.
    Galli, L.
    CANCER LETTERS, 2007, 256 (01) : 25 - 28
  • [4] Phase IV trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma
    Reni, M.
    Cereda, S.
    Passoni, P.
    Bonetto, E.
    Vigano, M. G.
    Balzano, G.
    Zerbi, A.
    Staudacher, C.
    Di Carlo, V
    ANNALS OF ONCOLOGY, 2006, 17 : XI51 - XI51
  • [5] Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma
    Reni, M.
    Cereda, S.
    Bonetto, E.
    Vigano, M. G.
    Passoni, P.
    Zerbi, A.
    Balzano, G.
    Nicoletti, R.
    Staudacher, C.
    Di Carlo, V.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (03) : 361 - 367
  • [6] Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma
    M. Reni
    S. Cereda
    E. Bonetto
    M. G. Viganò
    P. Passoni
    A. Zerbi
    G. Balzano
    R. Nicoletti
    C. Staudacher
    V. Di Carlo
    Cancer Chemotherapy and Pharmacology, 2007, 59
  • [7] Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine in pancreatic cancer: a randomized phase II trial
    Reni, M.
    Cereda, S.
    Aprile, G.
    Tronconi, M. C.
    Milandri, C.
    Passoni, P.
    Rognone, A.
    Balzano, G.
    Di Carlo, V.
    Villa, E.
    EJC SUPPLEMENTS, 2009, 7 (02): : 390 - 390
  • [8] ADJUVANT PEFG (CISPLATIN, EPIRUBICIN, 5-FLUOROURACIL, GEMCITABINE) OR GEMCITABINE IN PANCREATIC CANCER: A RANDOMIZED PHASE II TRIAL
    Reni, Michele
    Cereda, Stefano
    Aprile, Giuseppe
    Tronconi, Maria Chiara
    Milandri, Carlo
    Saletti, Piercarlo
    Passoni, Paolo
    Rognone, Alessia
    Fugazza, Clara
    Ceraulo, Domenica
    Balzano, Gianpaolo
    Di Carlo, Valerio
    Villa, Eugenio
    ANNALS OF ONCOLOGY, 2009, 20
  • [9] Phase IV trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma.
    Reni, M.
    Cereda, S.
    Passoni, P.
    Bonetto, E.
    Viganò, M. G.
    Balzano, G.
    Zerbi, A.
    Staudacher, C.
    Di Carlo, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 208S - 208S
  • [10] Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial
    Reni, Michele
    Balzano, Gianpaolo
    Aprile, Giuseppe
    Cereda, Stefano
    Passoni, Paolo
    Zerbi, Alessandro
    Tronconi, Maria Chiara
    Milandri, Carlo
    Saletti, Piercarlo
    Rognone, Alessia
    Fugazza, Clara
    Magli, Alessandro
    Di Muzio, Nadia
    Di Carlo, Valerio
    Villa, Eugenio
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (07) : 2256 - 2263
12345